Combination therapy has been shown to achieve higher efficacy; such as the combination of HT with mTOR inhibitors or CDK4/6 inhibitors are used for tumors with enhanced mTOR signaling and for CDK4/6 sensitive cancer, respectively [27,28,29,30,31,32,33,34,35]. Here, MTOR is linked to cancer.